Refreshing results…
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
UploadFLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years
Download from doi.orgBiology and therapeutic targeting of molecular mechanisms in MPNs
UploadVenetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
UploadMissing publications? Search for publications with a matching author name.